Kilitch Drugs (India) Corrects EGM Notice Typographical Error
Key highlights
- Kilitch Drugs (India) corrected one typographical error in its EGM notice explanatory statement.
- The corrigendum was published in two newspapers on 14 November 2026.
- The EGM remains scheduled for 16 November 2026 at 9:00 AM IST through VC/OAVM.
- The newspaper-publication filing was submitted to BSE and NSE on 15 November 2026.
powered by IRIS

Kilitch Drugs (India) Limited has corrected a typographical error in the explanatory statement to its EGM notice, while all other contents and the 16 November 2026 meeting schedule at 9:00 AM IST remain unchanged. The company published the corrigendum in two newspapers on 14 November 2026.
Know Kilitch Drugs (India) inside out
Results, valuation, peers and who's buying, in one view.
What did Kilitch Drugs (India) correct in its EGM notice?
Kilitch Drugs (India) corrected a typographical error in the explanatory statement accompanying its notice for the Extra Ordinary General Meeting. The company said the correction was made through a corrigendum, with the remaining contents of the original EGM notice continuing without change.
The filing was made under Regulations 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Regulation 30 deals with disclosures of material events and information by listed entities, while Regulation 47 covers publication of specified information in newspapers.
The disclosure does not identify a change to the EGM date, time, meeting format or other notice contents. It is therefore a corrective communication focused on the explanatory statement rather than a revised shareholder-meeting agenda.
When and where was the corrigendum published?
The corrigendum was published on 14 November 2026 in the Free Press Journal and Nava Shakti. Kilitch Drugs (India) submitted the newspaper-publication filing to BSE and NSE on 15 November 2026.
Newspaper publication provides a public record that shareholders have been informed of the correction. For investors following corporate actions, the exchange filing and the published corrigendum should be read together with the underlying EGM notice, since the company has stated that all other notice contents remain unchanged.
When is the Kilitch Drugs (India) EGM scheduled?
Kilitch Drugs (India) has scheduled its EGM for 16 November 2026 at 9:00 AM IST through video conferencing and other audio-visual means, or VC/OAVM. The company has specifically said that this schedule remains unchanged following the corrigendum.
The virtual format is consistent with several of the company's recent shareholder meetings. Its 34th Annual General Meeting was held on 27 August 2026, and the company has previously conducted EGM proceedings through VC/OAVM, including meetings on 13 March 2026 and 11 April 2023.
A VC/OAVM meeting allows eligible shareholders to participate without being physically present at a venue. The supplied disclosure does not state any revision to participation arrangements or voting procedures for the 16 November meeting.
Got a follow-up? Ask IRIS
Why does the correction matter to Kilitch Drugs (India) shareholders?
The correction matters because explanatory statements provide shareholders with context for matters placed before them at an EGM. Correcting an identified typographical error before the meeting helps ensure that the formal shareholder communication reflects the company's intended text.
At the same time, the limited nature of the disclosure is relevant. Kilitch Drugs (India) has not reported a change in the meeting date, time, format or other notice content, and the filing contains no financial revision, operating update, share-price information or outcome of the EGM.
The company has used shareholder meetings for significant corporate actions in the past. At its 13 March 2026 EGM, shareholders considered an increase in authorised capital and an issue of bonus shares. The present filing, however, only concerns a typographical correction and does not state whether the current EGM has comparable proposals.
What is the broader context of Kilitch Drugs (India) shareholder meetings?
Kilitch Drugs (India) has a record of holding annual and extraordinary shareholder meetings, with its recent AGM held on 27 August 2026. The company announced the current EGM on 23 October 2026, according to the meeting-history information provided.
The company's earlier EGM on 11 April 2023 was also conducted through VC/OAVM. The stated agenda at that meeting included the continuation of the managing director's appointment after attaining 70 years, the reappointment of an independent director, and the reappointment of a whole-time director.
For the current event, no comparable agenda details are set out in the supplied newspaper-publication filing. Investors should therefore distinguish between confirmed facts - the corrigendum, publication dates and unchanged meeting schedule - and matters not disclosed in this filing.
Conclusion
Kilitch Drugs (India) has issued a narrowly defined correction to the explanatory statement in its EGM notice and has preserved the original arrangements for the 16 November 2026 virtual meeting. The company completed the related newspaper publication on 14 November and submitted its exchange filing on 15 November under the SEBI listing-disclosure framework.
The next disclosed event is the EGM scheduled for 16 November 2026 at 9:00 AM IST through VC/OAVM. Shareholders and investors can watch for the meeting proceedings, voting results and any subsequent exchange disclosures that set out resolutions considered or approved at the meeting.


